Raleigh, NC-based AI developer Densitas has established a partnership with Intelerad Medical Systems to advance breast cancer screening.
Specifically, Intelerad will install Densitas’ intelliMammo platform, which will provide actionable information to clinical care teams, managers, and administrators using Intelerad’s IntelePACS diagnostic imaging and PenRad breast imaging reporting systems.
Ultimately, the partnership is aimed at strengthening clinical decision-making, increasing operational efficiencies, reducing costs, and improving mammography quality and mammography facility adherence with Mammography Quality Standards Act (MQSA) Enhancing Quality Using the Inspection Program (EQUIP) standards, Densitas said.
